CCRN · Cross Country Healthcare Inc

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on July 9, 2026.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

These restricted shares of common stock vest in three substantially equal installments. The installments will vest on March 31, 2027, March 31, 2028 and March 31, 2029.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

These restricted shares of common stock vest in three substantially equal installments. The installments will vest on March 31, 2027, March 31, 2028 and March 31, 2029.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

These restricted shares of common stock vest in three substantially equal installments. The installments will vest on March 31, 2027, March 31, 2028 and March 31, 2029.

Reflects an additional 4,471 shares of common stock that were inadvertently omitted from the Reporting Person's Form 3 filed on March 25, 2026.

These restricted shares of common stock vest in three substantially equal installments. The installments will vest on March 31, 2027, March 31, 2028 and March 31, 2029.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

These restricted shares of common stock vest in three substantially equal installments. The installments will vest on March 31, 2027, March 31, 2028 and March 31, 2029.

These restricted shares of common stock vest in three substantially equal installments. The installments will vest on March 31, 2027, March 31, 2028 and March 31, 2029.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2026.

The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.70 to $9.72 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within such range.

These restricted shares of common stock ("RSAs") vest in three substantially equal installments on each of December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.

These restricted shares of common stock ("RSAs") vest in three substantially equal installments on each of December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.

These restricted shares of common stock ("RSAs") will vest on December 18. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025.

These restricted shares of common stock ("RSAs") vest in three substantially equal installments on each of December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.

These restricted shares of common stock ("RSAs") vest in three substantially equal installments on each of December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.

These restricted shares of common stock ("RSAs") will vest on December 18. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025.

These restricted shares of common stock ("RSAs") will vest on December 18. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025.

These restricted shares of common stock ("RSAs") will vest on December 18. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025.

These restricted shares of common stock ("RSAs") vest in three substantially equal installments on each of December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.

These restricted shares of common stock ("RSAs") vest in three substantially equal installments on each of December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.

These restricted shares of common stock ("RSAs") vest in three substantially equal installments on each of December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.

These restricted shares of common stock ("RSAs") will vest on December 18. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025.

These restricted shares of common stock ("RSAs") vest in three substantially equal installments on each of December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.

These restricted shares of common stock ("RSAs") vest in three substantially equal installments on each of December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on June 1, 2025.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on June 1, 2025.

These shares were withheld to satisfy tax withholding obligation for restricted stock which vested on June 1, 2025.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on June 1, 2025.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2025.

These shares were withheld to satisfy tax withholding obligation for restricted stock which vested on March 31, 2025.

These shares were withheld to satisfy tax withholding obligation for restricted stock which vested on March 31, 2025.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2025.

These shares were withheld to satisfy tax withholding obligation for restricted stock which vested on March 31, 2025.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2025.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2025.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2025.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2025.

These shares were withheld to satisfy tax withholding obligation for restricted stock which vested on March 31, 2025.

These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on March 31, 2025.

These shares were withheld to satisfy tax withholding obligation for restricted stock which vested on March 31, 2025.